Veracyte Historical Cash Flow
| VCYT Stock | USD 23.51 0.71 2.93% |
Analysis of Veracyte cash flow over time is an excellent tool to project Veracyte future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 18.6 M or Stock Based Compensation of 38.1 M as it is a great indicator of Veracyte ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Veracyte latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Veracyte is a good buy for the upcoming year.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. About Veracyte Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Veracyte balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Veracyte's non-liquid assets can be easily converted into cash.
Veracyte Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Veracyte to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Veracyte operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Veracyte's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Veracyte current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.At this time, Veracyte's Stock Based Compensation is comparatively stable compared to the past year. Free Cash Flow is likely to gain to about 67 M in 2025, despite the fact that Change In Working Capital is likely to grow to (20.3 M).
Veracyte cash flow statement Correlations
Click cells to compare fundamentals
Veracyte Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Veracyte cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 1.1M | (1.5M) | (3.0M) | (1.7M) | (5.9M) | (5.6M) | |
| Change In Cash | 190.0M | (176.0M) | (19.0M) | 62.3M | 23.3M | 18.6M | |
| Stock Based Compensation | 13.0M | 22.5M | 26.7M | 33.1M | 36.2M | 38.1M | |
| Free Cash Flow | (12.5M) | (37.0M) | (1.0M) | 34.3M | 63.8M | 67.0M | |
| Change In Working Capital | (481K) | 4.2M | (16.4M) | (4.2M) | (21.3M) | (20.3M) | |
| Begin Period Cash Flow | 159.9M | 350.0M | 173.9M | 155.0M | 217.3M | 109.9M | |
| Other Cashflows From Financing Activities | 9.9M | 2.5M | 7.9M | 9.6M | (15.1M) | (14.3M) | |
| Depreciation | 7.9M | 19.6M | 25.9M | 27.2M | 23.5M | 24.6M | |
| Other Non Cash Items | 2.7M | 3.9M | 7.7M | 66.3M | 12.8M | 6.9M | |
| Capital Expenditures | 2.8M | 5.4M | 8.5M | 10.0M | 11.3M | 11.9M | |
| Total Cash From Operating Activities | (9.7M) | (31.6M) | 7.5M | 44.2M | 75.1M | 78.9M | |
| Change To Account Receivables | 955K | (8.6M) | 1.1M | 3.9M | (6.4M) | (6.1M) | |
| Net Income | (34.9M) | (75.6M) | (36.6M) | (74.4M) | 24.1M | 25.3M | |
| Total Cash From Financing Activities | 203.6M | 596.3M | 3.5M | 2.8M | 4.9M | 4.7M | |
| End Period Cash Flow | 350.0M | 173.9M | 155.0M | 217.3M | 240.6M | 128.5M | |
| Sale Purchase Of Stock | (3.8M) | (9.0M) | (3.2M) | (6.7M) | (6.1M) | (5.8M) | |
| Change Receivables | (6.2M) | 955K | (8.6M) | (4.5M) | (4.0M) | (4.2M) | |
| Net Borrowings | (292K) | (25.2M) | (100K) | (1.3M) | (1.2M) | (1.1M) | |
| Total Cashflows From Investing Activities | (3.8M) | (739.2M) | (29.4M) | 15.1M | (56.3M) | (59.1M) | |
| Cash And Cash Equivalents Changes | 81.3M | 190.0M | (174.5M) | (18.4M) | (16.5M) | (15.7M) | |
| Cash Flows Other Operating | (7.5M) | (1.0M) | 4.7M | (2.1M) | (2.4M) | (2.5M) | |
| Change To Netincome | 9.8M | 15.6M | 26.4M | 27.6M | 31.8M | 33.3M | |
| Change To Liabilities | (141K) | 711K | 5.2M | 152K | 174.8K | 166.1K | |
| Change To Operating Activities | 4.9M | (3.2M) | 9.1M | (9.0M) | (8.1M) | (7.7M) | |
| Investments | (1M) | 3M | (20.8M) | (8.8M) | (56.3M) | (53.5M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Veracyte Stock Analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.